Vertex Stock Tumbles 15% After Strong Earnings. What’s Spooking Investors. Barron’s Vertex Stock Falls After Pain-Drug Setback, Despite Stronger Earnings The Wall Street Journal Vertex’s trial failure, scrapped study cloud pain drug push; shares slump Reuters Vertex’s top scientist Altshuler to retire, next-generation pain drug fails Endpoints News Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain Yahoo Finance …
Read More »